Literature DB >> 15456916

Effect of genistein as a selective estrogen receptor beta agonist on the expression of Calbindin-D9k in the uterus of immature rats.

Geun-Shik Lee1, Kyung-Chul Choi, Hoe-Jin Kim, Eui-Bae Jeung.   

Abstract

Genistein, a phytoestrogen possessing a high affinity for estrogen receptor beta (ERbeta), is of increasing interest because of its possible influence on the physiology of mammalian reproductive tracts. Although estrogen has been demonstrated to regulate Calbindin-D9k (CaBP-9k) in the rat uterus as with other calcium binding proteins, the role of ERbeta on the modulation of CaBP-9k remains to be elucidated. To elucidate the effect of genistein as a selective ERbeta agonist on uterine expression of CaBP-9k mRNA and protein, immature female rats were injected with genistein daily for three consecutive days in a dose-dependent (0.4, 4, and 40 mg/kg/day) and time-dependent (40 mg/kg/day; 3, 6, 12, 24, 48, and 72 h) manner. Then, the expression of CaBP-9k mRNA and protein was analyzed by Northern hybridization and Western blot, respectively, in the absence or presence of ICI 182,780 (ICI), an estrogen antagonist. In addition, the protein levels of ERalpha and ERbeta and mRNA level of progesterone receptor (PR) were further measured following genistein treatment to elucidate which of ERs is involved in CaBP-9k modulation. In a dose-dependent experiment, the highest dose of genistein (40 mg/kg/day) for 3 days significantly induced uterine CaBP-9k protein as 17beta-estradiol (E2) did. In addition, its maximal mRNA expression was observed at 3 and 6 h, and it returned to control level at 24 h in a time-dependent experiment. In parallel with its mRNA level, the protein level of CaBP-9k was significantly induced by genistein at 3 h and sustained up to 48 h. The pretreatment with ICI, followed by genistein or E2, completely blocked genistein- and E2-induced CaBP-9k protein in the uterus of immature rats. Interestingly, genistein was demonstrated to induce ERalpha protein, but not ERbeta and PR mRNA, an E2-responsive gene, in this tissue. These results imply that genistein, an ERbeta ligand, may regulate CaBP-9k gene through ERalpha pathway. Taken together, the present study demonstrated that genistein enhanced CaBP-9k gene via ERalpha in the uterus of immature rats, suggesting that ERalpha may be a key mediator in uterine CaBP-9k gene induction in immature rats.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15456916     DOI: 10.1093/toxsci/kfh296

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  12 in total

Review 1.  NTP-CERHR expert panel report on the reproductive and developmental toxicity of genistein.

Authors:  Karl K Rozman; Jatinder Bhatia; Antonia M Calafat; Christina Chambers; Martine Culty; Ruth A Etzel; Jodi A Flaws; Deborah K Hansen; Patricia B Hoyer; Elizabeth H Jeffery; James S Kesner; Sue Marty; John A Thomas; David Umbach
Journal:  Birth Defects Res B Dev Reprod Toxicol       Date:  2006-12

Review 2.  Biology and physiology of Calbindin-D9k in female reproductive tissues: involvement of steroids and endocrine disruptors.

Authors:  Kyung-Chul Choi; Peter C K Leung; Eui-Bae Jeung
Journal:  Reprod Biol Endocrinol       Date:  2005-11-16       Impact factor: 5.211

3.  Modulatory role of genistein on placenta and maternal bone minerals composition: further insight into its influence on pregnancy and foetal development.

Authors:  Titilola Aderonke Samuel; Funmileyi Olubajo Awobajo; Taiwo Hafsah Akinsanya; Habeeb Shemilore Oyediran; Ikechukwu Eric Egege; Chiamaka Blessing Egede; Bukola Oluwasegun Timothy
Journal:  Biol Futur       Date:  2020-06-25

4.  Serum estrogen receptor bioactivity and breast cancer risk among postmenopausal women.

Authors:  Vanessa W Lim; Jun Li; Yinhan Gong; Aizhen Jin; Jian-Min Yuan; Eu Leong Yong; Woon-Puay Koh
Journal:  Endocr Relat Cancer       Date:  2014-02-27       Impact factor: 5.678

5.  Gene expression markers in circulating tumor cells may predict bone metastasis and response to hormonal treatment in breast cancer.

Authors:  Haiying Wang; Julian Molina; John Jiang; Matthew Ferber; Sandhya Pruthi; Timothy Jatkoe; Carlo Derecho; Yashoda Rajpurohit; Jian Zheng; Yixin Wang
Journal:  Mol Clin Oncol       Date:  2013-08-02

Review 6.  Biomarker genes for detecting estrogenic activity of endocrine disruptors via estrogen receptors.

Authors:  Eui-Man Jung; Beum-Soo An; Hyun Yang; Kyung-Chul Choi; Eui-Bae Jeung
Journal:  Int J Environ Res Public Health       Date:  2012-02-24       Impact factor: 3.390

7.  Gene alterations of ovarian cancer cells expressing estrogen receptors by estrogen and bisphenol a using microarray analysis.

Authors:  Kyung-A Hwang; Se-Hyung Park; Bo-Rim Yi; Kyung-Chul Choi
Journal:  Lab Anim Res       Date:  2011-06-22

8.  Uterine and placental expression of TRPV6 gene is regulated via progesterone receptor- or estrogen receptor-mediated pathways during pregnancy in rodents.

Authors:  Bo-Mi Lee; Geun-Shik Lee; Eui-Man Jung; Kyung-Chul Choi; Eui-Bae Jeung
Journal:  Reprod Biol Endocrinol       Date:  2009-05-21       Impact factor: 5.211

9.  Gonadotropin-releasing hormone (GnRH)-I and GnRH-II induce cell growth inhibition in human endometrial cancer cells: involvement of integrin beta3 and focal adhesion kinase.

Authors:  Dong Wook Park; Kyung-Chul Choi; Colin D MacCalman; Peter C K Leung
Journal:  Reprod Biol Endocrinol       Date:  2009-08-05       Impact factor: 5.211

Review 10.  Biological significance of calbindin-D9k within duodenal epithelium.

Authors:  Eui-Ju Hong; Eui-Bae Jeung
Journal:  Int J Mol Sci       Date:  2013-11-26       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.